Company intelligence / Profile preview

Anomera

Témiscaming, Quebec, Canada

Ownership: Private
Employees: ~27
Development stage: Other

Overview

Anomera has developed and commercialized a patented green chemistry process for producing carboxylated cellulose nanocrystals (CNC) used as sustainable, biodegradable, high-performance ingredients across industrial and consumer product sectors including cosmetics, bioplastics, coatings, adhesives, and concrete. Their products have been validated in collaboration with industry leaders and are being distributed globally.

Industry: Non-Drug Biotech

Partnerships

ChanelCrodaRayonierXerox Research Centre of Canada (XRCC)Biesterfeld

Beyond the preview

Go deeper on Anomera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anomera.

Explore the full profile